Microbot Medical Inc. has announced a significant milestone in its operations. On October 27, 2026, the company revealed that ELMNT IR, a multisite outpatient interventional radiology practice in California, has placed an order for up to a 12-month supply of its LIBERTY Endovascular Robotic System devices. This order marks ELMNT IR as the first Office-Based Laboratory customer globally to utilize the LIBERTY system and the company's first customer on the West Coast.

This development is crucial for Microbot Medical as it not only expands its customer base but also enhances its visibility in the competitive landscape of surgical and medical instruments. The LIBERTY Endovascular Robotic System is designed to improve the efficiency and effectiveness of interventional radiology procedures, which could lead to increased adoption in various medical facilities.

Background

Microbot Medical Inc., incorporated in Delaware, operates in the surgical and medical instruments and apparatus sector (SIC 3841). The company trades under the ticker symbol MBOT on the Nasdaq exchange. Recent filings indicate that Microbot has been actively engaging with investors and stakeholders, with multiple 8-K reports filed in October 2026 alone.

What the Filing Says

The recent filing states, "On October 27, 2026, Microbot Medical Inc. disseminated a press release announcing that ELMNT IR... has signed an order to purchase up to a 12-month supply of the Company’s LIBERTY Endovascular Robotic System devices." This highlights the company's commitment to expanding its market reach and product adoption.

Impact

This order from ELMNT IR may significantly impact Microbot Medical's growth trajectory, potentially leading to increased revenues and market share. The announcement is likely to resonate within the surgical and medical instruments industry, influencing competitors and encouraging similar practices to consider the LIBERTY system for their operations.

What's Next

The filing does not specify what happens next, but the successful integration of the LIBERTY system into ELMNT IR's operations could pave the way for additional orders and partnerships in the future.

For more information, the full press release can be accessed as Exhibit 99.1 in the SEC filing with accession number 0001493152-26-048640.